PuSH - Publikationsserver des Helmholtz Zentrums München

Wang, X. ; Rosikiewicz, W.* ; Sedkov, Y.* ; Mondal, B.* ; Martinez, T.* ; Kallappagoudar, S.* ; Tvardovskiy, A. ; Bajpai, R.* ; Xu, B.* ; Pruett-Miller, S.M.* ; Schneider, R. ; Herz, H.M.*

The MLL3/4 complexes and MiDAC co-regulate H4K20ac to control a specific gene expression program.

Life Sci. All. 5:e202201572 (2022)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The mitotic deacetylase complex MiDAC has recently been shown to play a vital physiological role in embryonic development and neurite outgrowth. However, how MiDAC functionally intersects with other chromatin-modifying regulators is poorly understood. Here, we describe a physical interaction between the histone H3K27 demethylase UTX, a complex-specific subunit of the enhancer-associated MLL3/4 complexes, and MiDAC. We demonstrate that UTX bridges the association of the MLL3/4 complexes and MiDAC by interacting with ELMSAN1, a scaffolding subunit of MiDAC. Our data suggest that MiDAC constitutes a negative genome-wide regulator of H4K20ac, an activity which is counteracted by the MLL3/4 complexes. MiDAC and the MLL3/4 complexes co-localize at many genomic regions, which are enriched for H4K20ac and the enhancer marks H3K4me1, H3K4me2, and H3K27ac. We find that MiDAC antagonizes the recruitment of UTX and MLL4 and negatively regulates H4K20ac, and to a lesser extent H3K4me2 and H3K27ac, resulting in transcriptional attenuation of associated genes. In summary, our findings provide a paradigm how the opposing roles of chromatin-modifying components, such as MiDAC and the MLL3/4 complexes, balance the transcriptional output of specific gene expression programs.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
5.781
0.000
1
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Sprache englisch
Veröffentlichungsjahr 2022
HGF-Berichtsjahr 2022
ISSN (print) / ISBN 2575-1077
e-ISSN 2575-1077
Zeitschrift Life Science Alliance
Quellenangaben Band: 5, Heft: 11, Seiten: , Artikelnummer: e202201572 Supplement: ,
Verlag EMBO Press
Verlagsort Heidelberg
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502800-001
Förderungen American Lebanese Syrian Associated Charities
National Cancer Institute
National Institutes of Health
Scopus ID 85133937630
PubMed ID 35820704
Erfassungsdatum 2022-09-30